189 results
Page 3 of 10
8-K
EX-99.2
w06erxj2hbx3f5xc6u
18 Jul 22
Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow
9:28pm
8-K
EX-99.3
5ozl8dia1e
18 Jul 22
Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow
9:28pm
8-K
EX-99.1
1cdmww7qi7fn
3 May 22
Invitae Reports $123.7 Million in Revenue in First Quarter of 2022 and Extends Cash Runway
4:08pm
424B5
snnas2tub10fiu0s
2 Mar 22
Prospectus supplement for primary offering
8:24am
8-K
EX-99.1
9ne0hn3
24 Feb 22
Invitae Reports $460.4 Million in Annual Revenue Driven by 1.17 Million in Billable Volume in 2021
4:06pm
8-K
EX-99.1
ygcgxb8o8r0a8bdt5w
11 Jan 22
Invitae Reports Preliminary 2021 Revenue of More Than $458 Million and Billable Volume of More Than 1.16 Million
4:20pm
S-8
EX-99.1
gd7jckb9yamu9ech
28 Dec 21
Registration of securities for employees
4:22pm
8-K
EX-99.1
77zq3fl
8 Nov 21
Invitae Reports $114.4 Million in Revenue Driven by 296,000 in Billable Volume in Third Quarter of 2021
4:01pm
S-3ASR
v8s vbh5n0m2
15 Sep 21
Automatic shelf registration
4:16pm
S-8
EX-99.1
gdp7mn9s9fli2tdew
14 Sep 21
Registration of securities for employees
4:07pm
8-K
EX-99.1
825rfl7m52rifasg
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
8-K
EX-99.2
1zrqpodu rnvx
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
S-8
EX-99.1
26petliqrpiox n3
9 Aug 21
Registration of securities for employees
5:27pm
8-K
EX-99.1
yikrgj10loumq
3 Aug 21
Invitae Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume in Second Quarter of 2021
4:08pm
8-K
EX-99.1
znh9gqc4h
11 Jun 21
Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer
8:03am